title: LTB_LON_test024

value: Male

value: No


title: PTB_LON_test028

status: Public on Aug 11 2010

type: RNA

city: Dallas

first: Damien

last: Chaussabel

state: TX

address: 3434 Live Oak

country: USA

institute: Baylor Institute for Immunology Research

description: Whole Blood from patient with active TB recruited in London. The subject was infected with Mycobacterium tuberculosis and confirmed as culture positive.

hyb_protocol: Hybridize 12-Sample Beadchip

scan_protocol: SentrixScanVersion 2.3.0.13  (This information is in the .XML file)

data_processing: The data were analysed using BeadStudio version 1.5.1.3 using the average chip normalization method.

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: Whole Blood from patient with Active TB

label_protocol: Biotinylated cRNA were generated following manufacturer protocols using the Illumina TotalPrep Amplification Kit from Ambion

extract_protocol: RNA was isolated using the MagMAX™-96 Blood RNA Isolation Kit (Applied Biosystems/Ambion, Austin, TX, USA) according to the manufacturer's instructions

tag: age

tag: gender

tag: ethnicity

value: Asian other

tag: illness

value: PTB

tag: geographical region

value: London

tag: bcg vaccinated

tag: region of birth

tag: tst

tag: smear of index case

tag: modal x-ray grade

value: Advanced

value: tuberculosis

value: Resistant Isoniazid + Ethambu


title: PTB_LON_test034

value: Female

value: Other

value: Yes

value: Moderate


title: PTB_LON_test053

value: South Asian

value: No disease


title: PTB_LON_test031

value: White


title: CON_LON_test040

description: Whole Blood from healthy control recruited in London. The subject was negative for skin test and IGRA test.

source_name: Whole Blood from healthy control

value: Black

value: Control (BCG+)


title: PTB_LON_test054


title: CON_LON_test044

value: Male


title: LTB_LON_test015

description: Whole Blood from patient with Latent TB  recruited in London .  The subject was an asymptomatic household contact of an active patient or a new entrant from an endemic country and tested positive by both IGRA and tuberculin skin test.

source_name: Whole Blood from patient with Latent TB

value: Latent

value: pulm

value: Sm+


title: CON_LON_test039

value: London


title: LTB_LON_test022

value: No

value: unknown

value: Minimal


title: PTB_LON_test026

value: PTB

value: tuberculosis

value: Resistant Streptomycin


title: LTB_LON_test018

value: Yes


title: PTB_LON_test027

value: South Asian

value: Moderate


title: PTB_LON_test032


title: LTB_LON_test020

value: No disease


title: PTB_LON_test023

value: Female

value: Advanced


title: CON_LON_test038

value: Control (BCG+)


title: LTB_LON_test021

value: Male

value: Black

value: Latent


title: LTB_LON_test014

value: London

value: pulm

value: Sm+


title: LTB_LON_test019

value: White


title: LTB_LON_test017

value: Other

value: unknown


title: CON_LON_test037


title: LTB_LON_test016


title: PTB_LON_test007

value: PTB

value: tuberculosis

value: Resistant Streptomycin, Ethio


title: PTB_LON_test005

value: Yes

value: Minimal


title: CON_LON_test035


title: LTB_LON_test012

value: South Asian

value: No

value: No disease


title: CON_LON_test036

value: Male

value: Control (BCG+)


title: LTB_LON_test013

value: Female

value: Asian other

value: Latent


title: LTB_SA_val051

description: Whole Blood from patient with Latent TB recruited in South Africa.  The subject tested positive for IGRA test.

value: Black

value: LATENT TB

value: South Africa


title: LTB_SA_val036


title: LTB_SA_val042


title: PTB_LON_test004

value: White

value: London

value: Advanced


title: PTB_LON_test049

value: PTB

value: tuberculosis


title: LTB_LON_test010

value: Yes

value: pulm

value: Sm+


title: PTB_SA_val019

description: Whole Blood from patient with active TB recruited in South Africa. The subject was infected with Mycobacterium tuberculosis and confirmed as culture positive.

value: No


title: LTB_LON_test009

value: Male

value: No disease


title: PTB_LON_test001

value: Resistant Isoniazid


title: LTB_SA_val048


title: PTB_SA_val020


title: LTB_SA_val049

value: Female


title: PTB_LON_test003

value: Minimal


title: PTB_LON_test002

value: Black

value: Resistant Pyrazinamide


title: LTB_SA_val046

value: LATENT TB

value: South Africa


title: LTB_SA_val043


title: PTB_SA_val018


title: LTB_SA_val047


title: LTB_SA_val045


title: PTB_SA_val016


title: LTB_SA_val044


title: PTB_SA_val017


title: PTB_SA_val015


title: PTB_SA_val010


title: PTB_SA_val012


title: LTB_SA_val035


title: LTB_SA_val037


title: LTB_SA_val034


title: PTB_SA_val014


title: LTB_SA_val032


title: LTB_SA_val040


title: LTB_SA_val039


title: PTB_SA_val011


title: LTB_SA_val025

value: Not Known


title: LTB_SA_val038


title: LTB_SA_val031


title: LTB_SA_val033


title: PTB_SA_val005


title: LTB_SA_val029


title: LTB_SA_val023


title: LTB_SA_val028


title: PTB_SA_val003


title: LTB_SA_val026


title: LTB_SA_val027


title: LTB_SA_val024


title: LTB_SA_val021


title: LTB_SA_val022


title: PTB_SA_val002


title: PTB_SA_val001


title: LTB_SA_val030